Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Oncology (Williston Park, N.Y.)|February 28, 2001
Rationale and dose-finding studies of the combination of irinotecan and a taxane on a weekly scheduleJ R Murren, K Blum, M Gallipoli, et al.
Archives of Internal Medicine|August 1, 1987
Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndromeC P Kales, J R Murren, R A Torres, et al.
Anti-Cancer Drug Design|July 20, 2000
Novobiocin-induced VP-16 accumulation and MRP expression in human leukemia and ovarian carcinoma cellsG Rappa, J R Murren, L M Johnson, et al.
Cancer|March 15, 1991
High-dose cisplatin plus dacarbazine in the treatment of metastatic melanomaJ R Murren, W DeRosa, H J Durivage, et al.
Surgery|December 1, 1992
P-glycoprotein expression and multidrug resistance in adrenocortical carcinomaS D Flynn, J R Murren, W M Kirby, et al.
Biochemical Pharmacology|January 26, 1993
Terfenadine (Seldane): a new drug for restoring sensitivity to multidrug resistant cancer cellsW N Hait, J F Gesmonde, J R Murren, et al.
The Yale Journal of Biology and Medicine|October 20, 1999
Peripheral blood progenitor cell cycle kinetics following priming with pIXY321 in patients treated with the "ICE" regimenJ R Murren, A Gollerkeri, S Anderson, et al.
Cancer Investigation|October 19, 2000
P-glycoprotein expression and multidrug resistance in cutaneous T-cell lymphomaA P Jillella, J R Murren, K K Hamid, et al.
World Journal of Gastroenterology|September 19, 2007
CTGF, intestinal stellate cells and carcinoid fibrogenesisM Kidd, I M Modlin, M D Shapiro, et al.
Pageof 4